riboflavin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on adverse event occurrence (oral or enteral supplement)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The evidence suggests that riboflavin may result in little to no difference in adverse events (odds ratio (OR) 1.92, 95% CI 0.16 to 22.56; P = 0.60; 1 study, 54 participants; low‐certainty evidence;.”
Quoted verbatim from Riboflavin supplements for blood pressure lowering in adults.. - Study
- meta-analysis
- Participants
- 54
- Population
- Adults with a history of migraine, riboflavin 400 mg/day for 12 weeks versus placebo (Schoenen 1998); this was the only one of the four included RCTs that reported adverse-event data.
Effect 1.92 odds ratio, 95% CI 0.16 to 22.56
Riboflavin supplements for blood pressure lowering in adults.2025PMID:41123035Permalink
Keep reading
- Everything the graph holds on riboflavin
- Every compound studied against Adverse event occurrence (oral or enteral supplement)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1N9RZ0H5D1YHW7M4NWQ4KYX